{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/","result":{"pageContext":{"chapter":{"id":"28c180bd-05b7-5bf7-8601-f61802a3f2b0","slug":"progestogen-only-pill","fullItemName":"Scenario: Progestogen-only pill","depth":2,"htmlHeader":"<!-- begin field 8cf29a43-fb4a-4a62-80fb-71b13b496522 --><h2>Scenario: Progestogen-only pill</h2><!-- end field 8cf29a43-fb4a-4a62-80fb-71b13b496522 -->","summary":"Covers the use of the progestogen-only pill (POP), including the available products; when to start it; the efficacy; how to manage common problems (such as missed pills); the advantages, disadvantages, risks, possible adverse effects and key drug interactions; and follow up requirements for this method of contraception.","htmlStringContent":"<!-- begin item c2a82b13-3dd7-4573-b603-7586df77e9c8 --><!-- begin field fcb0dc9e-15b9-4382-96ce-acbc015798ca --><p>From age 13 years to 60 years (Female).</p><!-- end field fcb0dc9e-15b9-4382-96ce-acbc015798ca --><!-- end item c2a82b13-3dd7-4573-b603-7586df77e9c8 -->","topic":{"id":"9ff99c6b-985a-5146-8ef5-665fc2b551bb","topicId":"832bfe6c-0c1e-4dca-89eb-7e914cf17833","topicName":"Contraception - progestogen-only methods","slug":"contraception-progestogen-only-methods","lastRevised":"Last revised in November 2019","chapters":[{"id":"e97a1889-5b3c-51c7-abca-435669821908","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9d1ba26b-0889-5782-a5dd-876d8d8965c8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e40c82f2-3cbd-56c2-b06f-b2d3bfae8a34","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3d3ddcb9-bbef-5443-9762-08bf7c296da4","slug":"changes","fullItemName":"Changes"},{"id":"5c8ed192-6ffb-5084-a621-3d1b14ea264d","slug":"update","fullItemName":"Update"}]},{"id":"c2b04259-e45f-54ea-ba94-5bc43975229b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c2cce341-0179-531a-bea7-9b8f9120b8c0","slug":"goals","fullItemName":"Goals"},{"id":"8aa31475-0c4c-5b7a-bbb7-82a288b1541c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"59f5527f-5091-5084-ab85-34cd87ab3424","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"14b43b64-8b02-5470-a6a1-41982cbed802","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1cd2c043-e2cd-5c97-9a82-32c5baf9f590","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"71e31498-8434-55e9-9802-459d2ed956f5","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"62d7d86a-7652-51fb-972e-f8113766a58c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ba99afb9-717a-59e6-b0af-a6fe316f6e0b","slug":"where-to-get-progestogen-only-contraception","fullItemName":"Where to get progestogen-only contraception"}]},{"id":"74f87f5c-2983-599c-9881-ad5d663100c0","fullItemName":"Management","slug":"management","subChapters":[{"id":"28c180bd-05b7-5bf7-8601-f61802a3f2b0","slug":"progestogen-only-pill","fullItemName":"Scenario: Progestogen-only pill"},{"id":"4c571c2d-718a-5351-ba2b-f3c8d69a15c4","slug":"progestogen-only-implant","fullItemName":"Scenario: Progestogen-only implant"},{"id":"a3632aab-62ce-5263-b365-24e12194e389","slug":"progestogen-only-injectables","fullItemName":"Scenario: Progestogen-only injectables"}]},{"id":"b040c0e0-cf32-51f5-8b09-18bca20a90c8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0b3c54f3-29e8-5d1b-af69-397a9b27760f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"654d1af0-9c4c-5d0a-90e6-d8cd8063b1c6","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b1383200-8981-5368-ba45-a0d6bbbe92a3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"05903434-c83e-5971-964b-85a3d8d7e8b3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e3f865d6-8f60-5c7a-b522-6e18d274c84c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"39d2eca9-efb9-5f08-b73b-15fb2a3d4896","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d93103c6-16a2-5c1d-92ce-7a991173c791","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"74f87f5c-2983-599c-9881-ad5d663100c0","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"08fc7bc9-04a1-55c2-a94d-2af6563c39d5","slug":"starting-a-progestogen-only-pill","fullItemName":"Starting a progestogen-only pill","depth":3,"htmlHeader":"<!-- begin field 124cbb50-9cac-4317-abf3-0042370def99 --><h3>Starting a progestogen-only pill</h3><!-- end field 124cbb50-9cac-4317-abf3-0042370def99 -->","summary":null,"htmlStringContent":"<!-- begin item eb0afaac-99ab-4304-aa8e-89a4e015480f --><!-- end item eb0afaac-99ab-4304-aa8e-89a4e015480f -->","subChapters":[{"id":"81fcaad4-1977-53ca-a4a4-12d4e396766f","slug":"assessment","fullItemName":"Assessment","depth":4,"htmlHeader":"<!-- begin field 2730e5bf-8d7a-4cb8-b8b5-5dc7985e3abb --><h4>How should I assess a woman who is considering starting the progestogen-only pill?</h4><!-- end field 2730e5bf-8d7a-4cb8-b8b5-5dc7985e3abb -->","summary":null,"htmlStringContent":"<!-- begin item baf41e85-f338-47e8-b695-41749edf9f1f --><!-- begin field 9df3e7ed-f586-402f-9b88-9387824475c7 --><ul><li>For information on assessing a woman considering starting a progestogen-only pill, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.</li></ul><!-- end field 9df3e7ed-f586-402f-9b88-9387824475c7 --><!-- end item baf41e85-f338-47e8-b695-41749edf9f1f -->","subChapters":[]},{"id":"9807ecc0-3870-5d56-ac50-07fc30b26d79","slug":"types-of-progestogen-only-pill","fullItemName":"Types of progestogen-only pill","depth":4,"htmlHeader":"<!-- begin field 3a901f37-4229-4ccb-b1df-a7a700eb06f3 --><h4>What types of progestogen-only pills (POPs) are available?</h4><!-- end field 3a901f37-4229-4ccb-b1df-a7a700eb06f3 -->","summary":null,"htmlStringContent":"<!-- begin item 020405fe-ea71-4a17-b477-a7a700eb044c --><!-- begin field e000d989-32cf-498c-8523-a7a700eb06f3 --><ul><li>The progestogen-only pills licensed in the UK are:<ul><li>Norgeston® (levonorgestrel 30 micrograms).</li><li>Noriday®, Micronor® (norethisterone 350 micrograms).</li><li>Cerazette®, Cerelle®, Feanolla®, Aizea® (desogestrel 75 micrograms).</li><li>A generic desogestrel 75 micrograms.</li></ul></li><li>Progestogen-only pills should be taken daily at the same time each day for 28 days, with no pill-free interval.</li></ul><!-- end field e000d989-32cf-498c-8523-a7a700eb06f3 --><!-- end item 020405fe-ea71-4a17-b477-a7a700eb044c -->","subChapters":[]},{"id":"9612df41-714d-5d5d-aa32-d3efbcc78e43","slug":"first-line-progestogen-only-pill","fullItemName":"First line progestogen-only pill","depth":4,"htmlHeader":"<!-- begin field dec70cdc-2899-40aa-a1e2-a6cd0105802e --><h4>Which progestogen-only pill should I offer first-line?</h4><!-- end field dec70cdc-2899-40aa-a1e2-a6cd0105802e -->","summary":null,"htmlStringContent":"<!-- begin item 5ae535a4-f070-4cb3-92bb-a6cd01057ecb --><!-- begin field dcbd8109-297e-41dc-9d54-a6cd0105802e --><ul><li>Any licensed progestogen-only pill (POP) may be used first-line.</li><li>However, possible adverse effects and/or rules about missed pills differ between products and this may affect their acceptability. For example:<ul><li>Irregular bleeding (particularly in the first few months) may be more of a problem with the desogestrel-only pill than with other POPs.</li><li>If the woman is unable to consistently take her pill at the same time every day, or within 3 hours of the usual pill time, consider prescribing desogestrel, which should be taken at the same time every day or within 12 hours of the usual pill time.</li></ul></li></ul><!-- end field dcbd8109-297e-41dc-9d54-a6cd0105802e --><!-- end item 5ae535a4-f070-4cb3-92bb-a6cd01057ecb -->","subChapters":[]},{"id":"5d63edf5-d605-5c0c-9fde-9f8ae340d39e","slug":"quantity-of-progestogen-only-pill","fullItemName":"Quantity of progestogen-only pill","depth":4,"htmlHeader":"<!-- begin field 0ec43d05-623a-4773-a61e-a6cd010c041a --><h4>What quantity of POP should I prescribe?</h4><!-- end field 0ec43d05-623a-4773-a61e-a6cd010c041a -->","summary":null,"htmlStringContent":"<!-- begin item 9f9fad8d-62f7-4f25-969d-a6cd010c02a0 --><!-- begin field d7a1d748-0ca7-4749-8eb4-a6cd010c041a --><ul><li>Prescribe 3–6 months' supply of progestogen-only pills at the first visit and up to 12 months' supply at follow up visits. </li></ul><!-- end field d7a1d748-0ca7-4749-8eb4-a6cd010c041a --><!-- end item 9f9fad8d-62f7-4f25-969d-a6cd010c02a0 -->","subChapters":[]},{"id":"35db8cc2-0794-5796-864f-3360726828e4","slug":"when-to-start","fullItemName":"When to start","depth":4,"htmlHeader":"<!-- begin field 6166dc28-9629-41ed-ac58-82f4bf57bd8c --><h4>When should a woman start a progestogen-only pill?</h4><!-- end field 6166dc28-9629-41ed-ac58-82f4bf57bd8c -->","summary":null,"htmlStringContent":"<!-- begin item dfba7f9b-0ddf-4d33-b36d-fdcf535a3f4b --><!-- begin field eee63038-d9f0-45c0-822d-b497dfbd9161 --><p>Specific advice for women who are amenorrhoeic, postpartum and breastfeeding, postpartum and not breastfeeding, post-termination of pregnancy, or post-miscarriage is summarized in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#when-to-start-amenorrhoea\">Amenorrhoea, postpartum, termination of pregnancy, or miscarriage</a>. </p><ul><li><strong>If the woman is <em>not </em>currently using a regular method of contraception or using a barrier method (such as condoms):</strong><ul><li>Start the progestogen-only pill (POP) on days 1 to 5 of the menstrual cycle.<ul><li>No additional contraception is required.</li></ul></li><li>If the POP is started at any other time in the menstrual cycle, and it is reasonably certain that the women is not pregnant and there has been no risk of conception (off-label use):<ul><li>Advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) for 48 hours after starting the pill.</li></ul></li><li>If pregnancy cannot be excluded and the women wishes to start a hormonal method of contraception without delay:<ul><li>Assess the need for emergency contraception (EC) and prescribe if necessary. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-emergency/\">Contraception - emergency</a>.</li><li>Prescribe the POP.</li><li>Advise the woman to have a pregnancy test no sooner 3 weeks after the last episode of unprotected sexual intercourse (UPSI).</li></ul></li></ul></li><li><strong>If the woman is starting the POP after oral EC:</strong><ul><li>For levonorgestrel, start the POP immediately, and advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) for the first 2 days.</li><li>For ulipristal acetate, start the POP 5 days after taking oral ulipristal acetate, and advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) during this time and for the first 2 days of taking the POP.</li><li>Advise the woman to have a pregnancy test no sooner than 3 weeks after the last episode of UPSI.</li></ul></li><li><strong>If the woman is changing from another POP:</strong><ul><li>Start the POP at any time</li><li>No additional contraception is required.</li></ul></li><li><strong>If the woman is changing from a combined hormonal contraceptive (CHC): </strong><ul><li>Start the POP on days 1 to 7 of the hormone-free interval (day 1 is the optimal time to switch).<ul><li>No additional contraception is required.</li></ul></li><li>If the POP is started on week 1 of normal CHC use:<ul><li>Advise the woman to abstain from sex or use a barrier method of contraception (such as condoms) for 48 hours after starting the POP.</li><li>If UPSI has occurred in the hormone-free interval, or week 1, continue the CHC for 7 consecutive days before switching.</li><li>If CHC cannot be continued, switch to the POP immediately. Consider the need for EC and a pregnancy test if pregnancy cannot be excluded. </li></ul></li><li>If the POP is started on weeks 2–3 of CHC use:<ul><li>No additional precautions are required if the method has been used correctly for the previous 7 days. </li></ul></li></ul></li><li><strong>If the woman is changing from an injectable progestogen-only contraceptive:</strong><ul><li>Start the POP up to 14 weeks after the last injection.<ul><li>No additional contraception is required.</li></ul></li><li>If the POP is started more than 14 weeks after the last injection. <ul><li>Advise the woman to abstain from sex or use a barrier method of contraception (such as condoms) for 48 hours after starting the POP.</li><li>Consider the need for EC, and a pregnancy test if pregnancy cannot be excluded.</li></ul></li></ul></li><li><strong>If the woman is changing from the progestogen-only implant:</strong><ul><li>Start the POP up to 3 years after insertion of the implant. <ul><li>No additional contraception is required.</li></ul></li><li>If the POP is started more than 3 years after insertion:<ul><li>Advise the woman to abstain from sex or use a barrier method of contraception (such as condoms) for 48 hours after starting the POP.</li><li>Consider the need for EC, and a pregnancy test if pregnancy cannot be excluded.</li></ul></li></ul></li><li><strong>If the woman is changing from a copper intrauterine device (Cu-IUD)</strong><ul><li>Start the POP at least 2 days before removal of the Cu-IUD.<ul><li> No additional contraception is required.</li></ul></li><li>If the POP is started on the day of the IUD removal, provided that there has been no UPSI in the preceding 7 days. <ul><li>Advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) for 48 hours after starting the POP.</li><li>Consider the need for EC, and a pregnancy test if pregnancy cannot be excluded.</li></ul></li></ul></li><li><strong>If the woman is changing from a levonorgestrel intrauterine system (LNG-IUS) </strong><ul><li>Start the POP at least 2 days before removal of the LNG-IUS.<ul><li>No additional contraception is required.</li></ul></li><li>If the POP is started on the day of removal of the LNG-IUS.<ul><li>Advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) for 48 hours after starting the POP.</li><li>Consider the need for EC, and a pregnancy test if pregnancy cannot be excluded.</li></ul></li></ul></li></ul><!-- end field eee63038-d9f0-45c0-822d-b497dfbd9161 --><!-- end item dfba7f9b-0ddf-4d33-b36d-fdcf535a3f4b -->","subChapters":[]},{"id":"097b7c48-8394-5035-ae16-c00dbc50b857","slug":"when-to-start-amenorrhoea","fullItemName":"When to start - Amenorrhoea","depth":4,"htmlHeader":"<!-- begin field b5ad253f-38e8-40ce-83c0-a6cd010d9147 --><h4>Amenorrhoea, postpartum, termination of pregnancy, or miscarriage</h4><!-- end field b5ad253f-38e8-40ce-83c0-a6cd010d9147 -->","summary":null,"htmlStringContent":"<!-- begin item 6c30adc7-13aa-4553-9e96-a6cd010d9041 --><!-- begin field 6059c1bb-5b54-470a-bb47-a6cd010d9147 --><ul><li><strong>If the woman is amenorrhoeic:</strong><ul><li>Start the progestogen-only pill (POP) at any time, provided it is reasonably certain that the woman is not pregnant.<ul><li>Additional contraception is required for 48 hours.</li><li>Consider the need for emergency contraception, and advise the woman to take a pregnancy test no sooner than 3 weeks after the last episode of unprotected sexual intercourse (UPSI). </li></ul></li></ul></li><li><strong>If the woman is postpartum (whether breastfeeding or not):</strong><ul><li>Start the POP at any time.<ul><li>If started before day 21 postpartum, no additional contraception is required.</li></ul></li><li>If started after day 21 postpartum, advise the woman to abstain from sex or use a barrier method of contraception (such as condoms) for 48 hours after starting the POP, unless she is using the lactational amenorrhoea method (LAM) of contraception. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-natural-family-planning/\">Contraception - natural family planning</a>, for more information on the LAM.<ul><li>Consider the need for emergency contraception (EC), and advise the woman to take a pregnancy test no sooner than 3 weeks after the last episode of UPSI. </li></ul></li></ul></li><li><strong>If the woman has had a miscarriage or termination of pregnancy: </strong><ul><li>If gestation is less than 24 weeks, ideally, start the POP on the day of a miscarriage, surgical termination, or first part of a medical termination.<ul><li>If the POP is started within 5 days of miscarriage or termination, no additional contraception is required.</li></ul></li><li>If the POP is started 5 days or more after miscarriage or termination, advise the woman to abstain from sex or use a barrier method of contraception (such as condoms) for 48 hours.<ul><li>Consider the need for EC, and advise the woman to take a pregnancy test no sooner than 3 weeks after the last episode of UPSI. </li></ul></li><li>If gestation is 24 weeks or more, treat as for a woman who is postpartum.</li></ul></li></ul><!-- end field 6059c1bb-5b54-470a-bb47-a6cd010d9147 --><!-- end item 6c30adc7-13aa-4553-9e96-a6cd010d9041 -->","subChapters":[]},{"id":"1789e78e-279a-52e6-9d73-1fd4cff642a5","slug":"when-to-start-excluding-pregnancy","fullItemName":"When to start - excluding pregnancy","depth":4,"htmlHeader":"<!-- begin field 12aa4e87-81eb-4000-b257-a6cd010da578 --><h4>Excluding pregnancy</h4><!-- end field 12aa4e87-81eb-4000-b257-a6cd010da578 -->","summary":null,"htmlStringContent":"<!-- begin item 9be7b0be-fdb6-4cee-960f-a6cd010da460 --><!-- begin field 39eae606-2a5d-46fd-912d-a6cd010da578 --><ul><li>Health professionals can be ‘reasonably certain’ that a woman is not pregnant if there are no signs or symptoms of pregnancy and one or more of the following criteria are met. The woman:<ul><li>Has not had sexual intercourse since the last normal menses.</li><li>Has used a reliable method of contraception correctly and consistently.</li><li>Is within the first 7 days of the onset of a normal menstrual period.</li><li>Is within 4 weeks postpartum for non-breastfeeding women.</li><li>Is within the first 7 days post-termination of pregnancy, or miscarriage.</li><li>Is fully or nearly fully breastfeeding, amenorrhoeic, and less than 6 months postpartum.</li><li>A pregnancy test is performed no sooner than 3 weeks since the last episode of unprotected sexual intercourse (UPSI) and is negative.</li></ul></li></ul><!-- end field 39eae606-2a5d-46fd-912d-a6cd010da578 --><!-- end item 9be7b0be-fdb6-4cee-960f-a6cd010da460 -->","subChapters":[]},{"id":"c54b1594-8c22-532a-a8d3-4da5171344a9","slug":"mechanism-of-action","fullItemName":"Mechanism of action","depth":4,"htmlHeader":"<!-- begin field a82fc03b-e37d-4743-ac0c-92af00f4ce4b --><h4>What is the mechanism of action of progestogen-only pills (POPs)?</h4><!-- end field a82fc03b-e37d-4743-ac0c-92af00f4ce4b -->","summary":null,"htmlStringContent":"<!-- begin item 19d37df4-6fd7-41e8-83dc-ed6f57e1d51b --><!-- begin field 5d520e2a-95c2-4958-9aee-d1ac95ec876a --><ul><li>Progestogen-only pills (POPs) have five independent modes of action:</li><ul><li>Suppression of ovulation — this occurs in varying degrees (97% in women taking desogestrel and about 60% in woman taking levonorgestrel [Norgeston®]).<br></li><li>Suppression of mid-cycle peaks of luteinizing hormone and follicle-stimulating hormone.<br></li><li>Production of 'hostile, blocked' mucus, resulting in poor sperm penetration.<br></li><li>Reduction in the number and size of endometrial glands and inhibition of progesterone receptor synthesis in the endometrium, preventing implantation.<br></li><li>Reduction in the activity of cilia in the Fallopian tube.<br></li><li>POPs prevent conception (even when ovulation is not suppressed) through various combinations of these mechanisms, with great inter-individual and intra-individual variation.</li></ul></ul><!-- end field 5d520e2a-95c2-4958-9aee-d1ac95ec876a --><!-- end item 19d37df4-6fd7-41e8-83dc-ed6f57e1d51b -->","subChapters":[]},{"id":"628e38ed-d306-5b2e-adce-af9e3b76679b","slug":"basis-for-recommendation-aa4","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field fd4fbbf0-c593-43fb-893e-a6cd0104d2c2 --><h4>Basis for recommendation</h4><!-- end field fd4fbbf0-c593-43fb-893e-a6cd0104d2c2 -->","summary":null,"htmlStringContent":"<!-- begin item aa4db5b9-1ae7-4b59-b222-a6cd0104d190 --><!-- begin field c21c69a7-6216-4632-95e6-a6cd0104d2c2 --><h5>Types of progestogen only pill</h5><ul><li>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>] and the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">BNF 71, 2016</a>].</li></ul><h5>Quantity of progestogen-only pill (POP) to prescribe</h5><ul><li>The FRSH recommends prescribing up to 12 months' supply at the first visit, however CKS recommends initially prescribing 3–6 months' supply until the first follow-up visit, to ensure the POP is suitable before prescribing a larger quantity.</li></ul><h5>When to start</h5><ul><li>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guidelines <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>], <em>UK Medical Eligibility Criteria for contraceptive use</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2016</a>], <em>Quick starting contraception</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2010a</a>], <em>Contraception after pregnancy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2017b</a>], and a statement from the FSRH clinical effectiveness unit [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015b</a>].</li></ul><h5>Mechanism of action</h5><ul><li><p>This information is based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline, <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>].</p></li></ul><!-- end field c21c69a7-6216-4632-95e6-a6cd0104d2c2 --><!-- end item aa4db5b9-1ae7-4b59-b222-a6cd0104d190 -->","subChapters":[]}]},{"id":"3f260364-35e7-500b-8e72-64080d9c838f","slug":"information-advice","fullItemName":"Information and advice","depth":3,"htmlHeader":"<!-- begin field d40441a0-7173-48d1-a7f8-bee55b88404f --><h3>What information and advice should I give a woman who is considering using a progestogen-only pill (POP)?</h3><!-- end field d40441a0-7173-48d1-a7f8-bee55b88404f -->","summary":null,"htmlStringContent":"<!-- begin item 91f1ac12-401d-4d3e-ae2c-19a74d5d3f29 --><!-- begin field d2d8de91-d75e-46ac-b357-f3b5ebeb1619 --><ul><li><strong>Discuss:</strong><ul><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#mechanism-of-action\">mechanism of action</a> of the progestogen-only pill (POP).</li><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#advantages-disadvantages\">advantages and disadvantages</a> of the POP.</li><li>The contraceptive <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#efficacy\">efficacy</a> of the POP.</li><li>What happens when the POP is stopped — advise the woman that normal fertility returns as soon as the POP is stopped.</li></ul></li><li><strong>Give advice on:</strong><ul><li>The importance of taking the pill regularly at a time of day that will aid adherence.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#missed-pill\">Missed pills</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#vomiting-or-diarrhoea\">Vomiting or diarrhoea</a> after taking the POP.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#risks-adverse-effects\">adverse effects</a> (such as <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#risks-adverse-effects\">unscheduled bleeding</a>) of the POP.</li><li>The possibility of <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#drug-interactions\">drug interactions</a>.<ul><li>Advise the woman to check with a healthcare professional before starting any new drug treatment (including herbal remedies).</li></ul></li></ul></li><li><strong>Also:</strong><ul><li>Provide written information on the POP. The <a href=\"http://www.fpa.org.uk/\" data-hyperlink-id=\"17df99a8-dd81-4c3f-b266-a931009d3260\">Family Planning Association</a> provides a useful <a href=\"http://www.fpa.org.uk/sites/default/files/progestogen-only-pill-your-guide.pdf\" data-hyperlink-id=\"a3db11c6-bd8e-4578-a970-a931009d3396\">leaflet</a> with information for women using the POP. </li><li>Offer verbal and/or written advice on long-acting reversible contraception (copper intrauterine device, levonorgestrel intrauterine system, progestogen-only injectables, progestogen-only implant, and the combined vaginal ring). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-ius-iud/\">Contraception - IUS/IUD</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> for more information on these methods of contraception.</li></ul></li></ul><!-- end field d2d8de91-d75e-46ac-b357-f3b5ebeb1619 --><!-- end item 91f1ac12-401d-4d3e-ae2c-19a74d5d3f29 -->","subChapters":[{"id":"ae47f0d2-b803-5f6a-af2f-0e5a71b1eb36","slug":"missed-pill","fullItemName":"Missed pill","depth":4,"htmlHeader":"<!-- begin field 62980408-c321-4efa-8aeb-a7a700e99516 --><h4>What missed pill advice should I give?</h4><!-- end field 62980408-c321-4efa-8aeb-a7a700e99516 -->","summary":null,"htmlStringContent":"<!-- begin item 06215d3a-2c4c-4ec5-8504-a7a700e992d6 --><!-- begin field 26204e36-9c2f-4bc6-bb38-a7a700e99516 --><ul><li>Check which progestogen-only pill (POP) the woman is taking and the time since the last pill was taken.<ul><li>For the desogestrel pill — a pill is missed if she is more than 12 hours late (that is more than 36 hours since taking the last pill).</li><li>For all other progestogen-only pills — a pill is missed if she is more than 2 hours late (that is more than 26 hours since taking the last pill).</li></ul></li><li>If the woman has missed any POP, she should:<ul><li>Take a pill as soon as possible.</li><li>Take the next pill at the normal time. This may mean taking two pills in 24 hours (the missed pill and the next one at the usual time).</li><li>Use a barrier method of contraception (such as condoms) for the next 48 hours, unless she is less than 6 months postpartum, fully breastfeeding, and amenorrhoeic.</li></ul></li><li>Consider prescribing emergency contraception if unprotected sexual intercourse has taken place after the missed pill and within 48 hours of restarting the POP. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-emergency/\">Contraception - emergency</a>.</li></ul><!-- end field 26204e36-9c2f-4bc6-bb38-a7a700e99516 --><!-- end item 06215d3a-2c4c-4ec5-8504-a7a700e992d6 -->","subChapters":[]},{"id":"621055ce-456d-563b-97ab-c51e9affc219","slug":"pregnancy","fullItemName":"Pregnancy","depth":4,"htmlHeader":"<!-- begin field c5f5fb01-8425-4816-8f87-8866a09d4668 --><h4>How should I manage a woman who becomes pregnant whilst using the progestogen-only pill?</h4><!-- end field c5f5fb01-8425-4816-8f87-8866a09d4668 -->","summary":null,"htmlStringContent":"<!-- begin item 82f67087-bf3e-47e1-8df2-f36e89945705 --><!-- begin field 8fabd022-be6c-418f-ae9c-183ee407b034 --><ul><li>If a woman is found to be pregnant whilst using the progestogen-only pill (POP) and she wishes to continue with the pregnancy:<ul><li>Advise her to stop taking the POP.</li><li>Inform her that there is no evidence of harm to the baby or the mother if pregnancy occurs while using the POP.</li><li>Be alert to the possibility of an ectopic pregnancy. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/ectopic-pregnancy/\">Ectopic pregnancy</a>.</li></ul></li></ul><!-- end field 8fabd022-be6c-418f-ae9c-183ee407b034 --><!-- end item 82f67087-bf3e-47e1-8df2-f36e89945705 -->","subChapters":[]},{"id":"dc7f112c-75a0-589e-a381-1b66b1178de9","slug":"vomiting-or-diarrhoea","fullItemName":"Vomiting or diarrhoea","depth":4,"htmlHeader":"<!-- begin field 0917a38d-8327-4e4b-a4bd-a8a2947fdb85 --><h4>What advice should I give a woman taking progestogen-only pills about vomiting or diarrhoea?</h4><!-- end field 0917a38d-8327-4e4b-a4bd-a8a2947fdb85 -->","summary":null,"htmlStringContent":"<!-- begin item 9453c37c-491d-4bb1-8d39-9bb84ea8cd9b --><!-- begin field 069d28a5-6b0b-4785-b651-102f2e2fec65 --><ul><li>If a woman vomits within 2 hours of pill taking, another pill should be taken as soon as possible. If the subsequent pill is missed, she should be given the instructions for <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#missed-pill\">missed pills</a>.</li><li>If vomiting or diarrhoea persists for more than 24 hours, advise her to:<ul><li>Follow the instructions for missed pills, counting each day of vomiting and/or diarrhoea as a missed pill.</li><li>Avoid sexual intercourse or use a barrier method of contraception (such as condoms) during the illness and for 48 hours afterwards.</li></ul></li></ul><!-- end field 069d28a5-6b0b-4785-b651-102f2e2fec65 --><!-- end item 9453c37c-491d-4bb1-8d39-9bb84ea8cd9b -->","subChapters":[]},{"id":"3c732222-18cc-5704-bdee-748126f2c310","slug":"basis-for-recommendation-2ae","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f3b24615-e27d-4137-84ac-a6cd01101b53 --><h4>Basis for recommendation</h4><!-- end field f3b24615-e27d-4137-84ac-a6cd01101b53 -->","summary":null,"htmlStringContent":"<!-- begin item 2ae6cce9-3085-42fb-8ad6-a6cd011019f9 --><!-- begin field 17ef7c03-7b77-44e0-83ea-a6cd01101b53 --><h5>Information and advice</h5><ul><li>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline, <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>].</li></ul><h5>Missed pill</h5><ul><li><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>].</p></li></ul><h5>Pregnancy</h5><ul><li><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>], and the manufacturer's Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2016a</a>].</p></li></ul><h5>Vomiting or diarrhoea</h5><ul><li>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Drug interactions with hormonal contraception</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2017a</a>].</li></ul><!-- end field 17ef7c03-7b77-44e0-83ea-a6cd01101b53 --><!-- end item 2ae6cce9-3085-42fb-8ad6-a6cd011019f9 -->","subChapters":[]}]},{"id":"4edbca05-3b18-55dd-8ece-a0edb0f33ce4","slug":"advantages-disadvantages","fullItemName":"Advantages and disadvantages","depth":3,"htmlHeader":"<!-- begin field 928ee9e0-32f9-42ff-b747-8ecee7509b1b --><h3>What are the advantages and disadvantages of progestogen-only pills (POPs)?</h3><!-- end field 928ee9e0-32f9-42ff-b747-8ecee7509b1b -->","summary":null,"htmlStringContent":"<!-- begin item 0fb0b440-ac35-4595-a708-4db55a93c77d --><!-- begin field 391ecd90-62b0-4f93-a4b1-ddc3329cb954 --><div><strong>Advantages</strong></div><ul><li>The progestogen-only pill (POP) is very effective when taken correctly and is more <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#efficacy\">effective</a> than barrier methods of contraception. </li><li>Sex need not be interrupted to use the POP.</li><li>It can be used by women for whom the combined oral contraceptive is not suitable.</li><li>It may reduce the risk of endometrial cancer.</li><li>Desogestrel may be beneficial in managing dysmenorrhoea.</li><li>Normal fertility returns when the POP is stopped.</li></ul><h4>Disadvantages</h4><div><ul><li>Pills must be taken at the same time each day, or within 3 hours, except for the desogestrel-only pill, which must be taken within 12 hours to be effective.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#risks-adverse-effects\">Adverse effects</a> (such as unscheduled bleeding and breast tenderness) may be experienced by some women when they first start a POP, however these are transient. </li><li>The POP does not protect against sexually transmitted infections (STIs). People at risk of STIs should be advised to also use a barrier method of contraception (such as condoms). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-barrier-methods-spermicides/\">Contraception - barrier methods and spermicides</a>.</li></ul></div><!-- end field 391ecd90-62b0-4f93-a4b1-ddc3329cb954 --><!-- end item 0fb0b440-ac35-4595-a708-4db55a93c77d -->","subChapters":[{"id":"03a93188-42bd-53db-8d58-a4e3489fd6dd","slug":"basis-for-recommendation-352","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 98fed0d1-cd2b-4745-a879-313ab4947f16 --><h4>Basis for recommendation</h4><!-- end field 98fed0d1-cd2b-4745-a879-313ab4947f16 -->","summary":null,"htmlStringContent":"<!-- begin item 3523178f-4b00-4b13-b9f1-550ea999e891 --><!-- begin field 57d48f8c-7645-4a69-a4e9-55eb7f1ff596 --><p>This information is based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline, <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>] and the manufacturer's Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2016a</a>].</p><!-- end field 57d48f8c-7645-4a69-a4e9-55eb7f1ff596 --><!-- end item 3523178f-4b00-4b13-b9f1-550ea999e891 -->","subChapters":[]}]},{"id":"bfd725ff-18ba-5e02-807f-5916bec30702","slug":"risks-adverse-effects","fullItemName":"Risks and adverse effects","depth":3,"htmlHeader":"<!-- begin field 70f71773-f3e6-44ca-9d9e-b9107f22e738 --><h3>What are the possible risks and adverse effects of progestogen-only pills (POPs)?</h3><!-- end field 70f71773-f3e6-44ca-9d9e-b9107f22e738 -->","summary":null,"htmlStringContent":"<!-- begin item a2486393-d1f2-481f-aa5f-1a44e4ecc0b6 --><!-- begin field 55f2e85a-b640-439e-9565-e90382fc22ac --><ul><li><strong>Menstrual irregularities </strong>—<strong> </strong>changes in bleeding patterns are common. For more<strong> </strong>information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#unscheduled-bleeding\">unscheduled bleeding</a>.</li><li><strong>Breast tenderness </strong>— this is usually transient. However, if it is persistently troublesome, consider changing to <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#types-of-progestogen-only-pill\">another progestogen-only pill</a> (POP), or to another contraceptive method. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a> for information on other contraceptive methods.</li><li><strong>Ovarian cysts</strong> — POP use is associated with around 30% higher risk of developing spontaneously reversible ovarian cysts.</li><li><strong>Ectopic pregnancy</strong> — there is a small increased risk of ectopic pregnancy in women using POPs (with the exception of desogestrel), but the absolute risk is lower than if not using contraception. Around 1 in 10 pregnancies that occur may be ectopic.</li><li><strong>Increased cancer risk </strong>— there is a possible increased risk of breast cancer with the use of POPs. However, this risk is very small compared with the overall risk of developing breast cancer, and 10 years after stopping the POP, the risk of developing breast cancer is the same as for women who have never used hormonal contraceptives.<ul><li>Compared with women who have never used the POP:<ul><li>In 10,000 women who use the POP for up to 5 years and stop by the age of 20 years, less than 1 additional case of breast cancer will be diagnosed up to 10 years afterwards.</li><li>In 10,000 women who use the POP for up to 5 years and stop by the age of 30 years, about 2–3 extra cases of breast cancer (in addition to 44 cases per 10,000 women in this age group that have never used oral contraceptives) will be diagnosed up to 10 years afterwards.</li><li>In 10,000 women who use the POP for up to 5 years and stop by the age of 40 years, about 10 extra cases of breast cancer (in addition to 160 cases per 10,000 women in this age group that have never used oral contraceptives) will be diagnosed up to 10 years afterwards.</li></ul></li><li>There is no evidence for any increased risk of other cancers and the POP may reduce the risk of endometrial cancer.</li></ul></li><li><strong>There is no evidence that the POP causes:</strong><ul><li>Depression and mood changes (although mood changes have been reported. Panic attacks have also been reported in women using desogestrel).</li><li>Headache.</li><li>Libido changes (however this is listed in the manufacturer's Summary of Product Characteristics).</li><li>Cardiovascular disease, including myocardial infarction, venous thromboembolism, and stroke.</li><li>Weight changes (although this has been reported in women using the POP in clinical trials).</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">BJCP, 2018</a>]</p><!-- end field 55f2e85a-b640-439e-9565-e90382fc22ac --><!-- end item a2486393-d1f2-481f-aa5f-1a44e4ecc0b6 -->","subChapters":[{"id":"aa295df9-14ea-5082-9e66-26c10f143b48","slug":"unscheduled-bleeding","fullItemName":"Unscheduled bleeding","depth":4,"htmlHeader":"<!-- begin field 5698dfb6-db66-48d7-b744-a6ce008f52c6 --><h4>How should I manage unscheduled bleeding in a woman using a progestogen-only pill?</h4><!-- end field 5698dfb6-db66-48d7-b744-a6ce008f52c6 -->","summary":null,"htmlStringContent":"<!-- begin item fe6695d0-a664-4e56-ab00-a6ce007b4f53 --><!-- begin field 6779470e-f1d8-43e0-9545-a6ce008f52c6 --><ul><li><strong>Exclude and/or manage:</strong><ul><li>Situations which could compromise the effectiveness of progestogen-only pills (POPs) such as missed pills, drug interactions, and vomiting or diarrhoea.</li><li>Situations which could result in unscheduled bleeding, such as:<ul><li>Sexually transmitted infections (STIs) — as a minimum, test for <em>Chlamydia trachomatis. </em>The risk of STIs is increased if the woman is under 25 years, has a new sexual partner, or has had more than one sexual partner in the last year. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a>.</li><li>Pregnancy — perform a pregnancy test.</li><li>Gynaecological conditions such as cervical cancer — if this is suspected, refer the woman using a suspected cancer pathway referral (for an appointment within 2 weeks). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/\">Gynaecological cancers - recognition and referral</a>.</li><li>Endometrial cancer — refer women aged 45 and older using a suspected cancer pathway referral (for an appointment within 2 weeks) if they have menstrual irregularities. Refer women younger than 45 years if they have risk factors for endometrial cancer and persistent, problematic bleeding after the first 3 months of use, or if they present with a change in bleeding pattern after at least 3 months of use. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/\">Gynaecological cancers - recognition and referral</a>.</li></ul></li></ul></li><li><strong>Consider performing a speculum and pelvic examination:</strong><ul><li>For persistent bleeding beyond the first 3 months of use — unscheduled bleeding is common in the first 3 months of starting a new hormonal contraceptive method.</li><li>For new symptoms or a change in bleeding after at least 3 months of use.</li><li>If the woman has not participated in the NHS Cervical Screening Programme regularly. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cervical-cancer-hpv/\">Cervical cancer and HPV</a>.</li><li>If requested by the woman.</li><li>If there are other symptoms such as pelvic pain, dyspareunia, or post-coital bleeding. </li></ul></li><li>If no other underlying cause of irregular bleeding is suspected, and speculum and pelvic examination is normal, the bleeding can be assumed to be caused by the POP. Providing the woman has no other symptoms:<ul><li>Reassure her that unscheduled bleeding is common in POP users.</li><li>Advise her that although bleeding may settle with time, there is no evidence to indicate which women may become amenorrhoeic, or which women may experience persistent irregular bleeding, or for how this will continue. As a general guide, over 12 months' of use, over a 3-month interval:<ul><li>5 in 10 women will be amenorrhoeic or have infrequent bleeding.</li><li>4 in 10 women will have 3–5 bleeding/spotting episodes (regular bleeding).</li><li>1 in 10 women will have 6 or more bleeding/spotting episodes (frequent bleeding).</li><li>2 in 10 women will have bleeding/spotting episodes lasting more than 14 days (prolonged bleeding).</li></ul></li><li>If the bleeding is unacceptable to the woman, consider changing to:<ul><li>A different POP, although there is no evidence that changing the progestogen type or dose improves bleeding.</li><li>A different type of contraceptive method. See the CKS topic on Contraception - assessment for information on other contraceptive methods.</li></ul></li></ul></li></ul><!-- end field 6779470e-f1d8-43e0-9545-a6ce008f52c6 --><!-- end item fe6695d0-a664-4e56-ab00-a6ce007b4f53 -->","subChapters":[]},{"id":"441a4350-1cd4-5788-9cee-4190e4055003","slug":"basis-for-recommendation-ada","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 09236f97-f64d-47be-861f-448553ea89c9 --><h4>Basis for recommendation</h4><!-- end field 09236f97-f64d-47be-861f-448553ea89c9 -->","summary":null,"htmlStringContent":"<!-- begin item ada74ae4-51c7-4007-ac5f-3b9bd19825f0 --><!-- begin field 961e4e50-83f4-4ddd-a9b1-52c6e62c61c9 --><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guidelines, <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>], <em>Problematic bleeding with hormonal contraception </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015c</a>], the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and </em><em>referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">NICE, 2015</a>], and the manufacturer's Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2016a</a>].</p><h5>Endometrial cancer</h5><ul><li>NICE advises considering using a suspected cancer pathway referral (for an appointment within 2 weeks) for women aged under 55 years with post-menopausal bleeding. However, the FSRH advises that an endometrial biopsy should be considered in women aged 45 years or over and in women under 45 years with risk factors for endometrial cancer who have persistent problematic bleeding after the first 3 months of using a method, or who present with a change in bleeding pattern [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">NICE, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015c</a>].</li></ul><!-- end field 961e4e50-83f4-4ddd-a9b1-52c6e62c61c9 --><!-- end item ada74ae4-51c7-4007-ac5f-3b9bd19825f0 -->","subChapters":[]}]},{"id":"11b165f2-6d55-5c1d-8ae6-ab7d9816cfb2","slug":"efficacy","fullItemName":"Efficacy","depth":3,"htmlHeader":"<!-- begin field 1b18de1b-d8fa-487d-af27-933e6eab8d3d --><h3>How effective are progestogen-only pills (POPs) at preventing pregnancy?</h3><!-- end field 1b18de1b-d8fa-487d-af27-933e6eab8d3d -->","summary":null,"htmlStringContent":"<!-- begin item 28710306-aa7b-4f7c-97d0-b310e87385e1 --><!-- begin field dd068574-5eb8-4bec-808d-05fadfc5b4c7 --><ul><li>For a comparison of the efficacy of progestogen-only pills (POPs) with other methods of contraception, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/background-information/comparative-effectiveness-of-contraceptive-methods/\">Comparative efficacy</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.<ul><li>When used perfectly (consistently and correctly), 0.3% of women will conceive within the first year of use due to method failure.</li><li>When used typically, 9% of women will conceive within the first year of use due to method failure or user failure.</li></ul></li></ul><!-- end field dd068574-5eb8-4bec-808d-05fadfc5b4c7 --><!-- end item 28710306-aa7b-4f7c-97d0-b310e87385e1 -->","subChapters":[{"id":"9f1c486c-c9eb-524e-b414-5cc31d412c57","slug":"basis-for-recommendation-864","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 18d58ef8-26e1-4ccc-900a-7f7e3af93360 --><h4>Basis for recommendation</h4><!-- end field 18d58ef8-26e1-4ccc-900a-7f7e3af93360 -->","summary":null,"htmlStringContent":"<!-- begin item 8645f5e5-e957-4e36-bd7b-3e68b26ae8f0 --><!-- begin field bfbf136a-a87b-4f14-a57c-25b1a7499749 --><p>This information is based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Progestogen-only pills </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>], and on expert opinion in the medical textbook <em>Contraceptive technology</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">Hatcher, 2011</a>].</p><!-- end field bfbf136a-a87b-4f14-a57c-25b1a7499749 --><!-- end item 8645f5e5-e957-4e36-bd7b-3e68b26ae8f0 -->","subChapters":[]}]},{"id":"056fdf29-75ce-538f-8b97-9fc70e001abc","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 0764ca72-97d5-4ad7-a407-fa88d69a8e23 --><h3>What are the key drug interactions for progestogen-only pills?</h3><!-- end field 0764ca72-97d5-4ad7-a407-fa88d69a8e23 -->","summary":null,"htmlStringContent":"<!-- begin item cd0170e6-81ed-4cd9-9642-d44a35e90d26 --><!-- begin field 80079242-b4d1-4d85-a1df-c3ada6bc3527 --><h4>Liver enzyme-inducing drugs</h4><ul><li>Advise the woman that liver enzyme-inducing drugs may reduce the efficacy of progestogen–only pills (POPs). Examples of liver enzyme-inducing drugs are:<ul><li>Antibiotics — rifampicin and rifabutin are very potent liver enzyme inducers.</li><li>Antiepileptic drugs such as carbamazepine, oxcarbazepine, phenytoin, barbiturates, primidone, and topiramate.<ul><li>Topiramate is associated with a risk of fetal malformations and can impair the effectiveness of hormonal contraceptives. Before initiating topiramate in a woman of childbearing potential, pregnancy testing should be performed. The patient should be fully informed of the risks related to the use of topiramate during pregnancy. Ensure that women and girls of childbearing potential are advised that they should be using a highly effective method of contraception [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2017</a>]. </li></ul></li><li>Antiretrovirals such as ritonavir, ritonavir-boosted protease inhibitors, efavirenz, and nevirapine.</li><li>St John's wort — advise women taking the POP not to take herbal products containing St John’s wort.</li></ul></li><li><strong>If a woman is on short-term treatment (2 months or less) with a liver enzyme-inducing drug:</strong><ul><li>Advise her to stop the POP and change to an alternative contraceptive method unaffected by liver enzyme-inducing drugs.<ul><li>For example having a one-off progestogen-only injection to cover the short-term treatment and for 28 days after.</li></ul></li><li>If this is not acceptable or possible:<ul><li>Continue the POP. </li><li>Advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) while taking, and for 28 days after stopping, the liver enzyme-inducing drug.</li></ul></li><li>Consider the need for emergency contraception (EC) if unprotected sexual intercourse has taken place while the efficacy of the POP may have been reduced, for example if the woman has already started treatment with a liver enzyme-inducing drug. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-emergency/\">Contraception - emergency</a>.</li></ul></li></ul><ul><li><strong>If a woman is on long-term treatment (more than 2 months) with a liver enzyme-inducing drug:</strong><ul><li>Advise her to change to an alternative contraceptive method unaffected by liver enzyme-inducing drugs (such as barrier methods or the progestogen-only injectable). </li><li>Do not increase the dose of the POP.</li><li>Consider the need for EC if sexual intercourse has taken place while the efficacy of the POP may have been reduced, for example if the woman has already started treatment with a liver enzyme-inducing drug. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-emergency/\">Contraception - emergency</a>.</li></ul></li></ul><h4>Griseofulvin</h4><ul><li><strong>Griseofulvin may reduce the contraceptive effect of POPs </strong>— advise the woman to change to an alternative method of contraception unaffected by griseofulvin. </li></ul><h4>Lamotrigine</h4><ul><li><strong>Lamotrigine increases plasma levels of progestogen </strong>— monitor for adverse effects of POP.</li></ul><h4>Ulipristal acetate (Esmya®)</h4><ul><li>Ulipristal acetate 5 mg (Esmya®) is licensed for the pre-operative treatment of moderate to severe symptoms of uterine fibroids. The dose (5 mg daily) is lower than that used for emergency contraception (30 mg as a one-off dose). The manufacturers of Esmya® advise avoiding concomitant use of POPs as they may reduce the efficacy of ulipristal.</li></ul><!-- end field 80079242-b4d1-4d85-a1df-c3ada6bc3527 --><!-- end item cd0170e6-81ed-4cd9-9642-d44a35e90d26 -->","subChapters":[{"id":"a9922fab-81c3-590f-99f7-3aa991b3904b","slug":"basis-for-recommendation-4f3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 73142ade-aaa0-4e8d-abb2-f0e37effa333 --><h4>Basis for recommendation</h4><!-- end field 73142ade-aaa0-4e8d-abb2-f0e37effa333 -->","summary":null,"htmlStringContent":"<!-- begin item 4f369a24-bfeb-47b4-9ca8-a9e32572d74f --><!-- begin field ce90acd6-6a40-497a-8b5e-51a286c4dad8 --><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guidelines, <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>], <em>Drug interactions with hormonal contraception</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2017a</a>], and the manufacturer's Summaries of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">ABPI, 2016b</a>].</p><!-- end field ce90acd6-6a40-497a-8b5e-51a286c4dad8 --><!-- end item 4f369a24-bfeb-47b4-9ca8-a9e32572d74f -->","subChapters":[]}]},{"id":"794ee3ce-4c53-504c-88a6-42fd41331a55","slug":"follow-up","fullItemName":"Follow up","depth":3,"htmlHeader":"<!-- begin field 694db6c5-f35c-4ab8-8700-e79eb2603d12 --><h3>What follow up should I consider for a woman using a progestogen-only pill (POP)?</h3><!-- end field 694db6c5-f35c-4ab8-8700-e79eb2603d12 -->","summary":null,"htmlStringContent":"<!-- begin item 1694dec5-2f66-4fd8-830a-e59f51e6b747 --><!-- begin field c0b5628b-f3c4-4488-95b0-809802cfa64e --><ul><li>Arrange follow up 10–12 weeks after the first prescription of a progestogen-only pill (POP) and then at least every 12 months thereafter, provided there are no troublesome adverse effects.</li><li>At the follow up visit:<ul><li>Check the woman's blood pressure and body mass index.</li><li>Assess the woman for any new risk factors that may mean this method is no longer suitable. For more information, see the topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>. </li><li>Ask about any <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#risks-adverse-effects\">adverse effects</a>. </li><li>Check that the woman is taking the POP correctly and consistently.</li><li>Check her knowledge of what to do if a pill is <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#missed-pill\">missed</a>.</li><li>Remind her about possible <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/management/progestogen-only-pill/#drug-interactions\">drug interactions</a>.</li></ul></li><li>Offer verbal and/or written advice on long-acting reversible contraception (copper intrauterine device, levonorgestrel intrauterine system, progestogen-only injectables, progestogen-only implant, and the combined hormonal vaginal ring). For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-ius-iud/\">Contraception - IUS/IUD</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a>.</li></ul><!-- end field c0b5628b-f3c4-4488-95b0-809802cfa64e --><!-- end item 1694dec5-2f66-4fd8-830a-e59f51e6b747 -->","subChapters":[{"id":"81077b8b-372e-5f3a-a748-da76dbee3539","slug":"duration-of-use","fullItemName":"Duration of use","depth":4,"htmlHeader":"<!-- begin field 590c5261-9276-4d79-a403-a6ce0093f366 --><h4>How long should the progestogen-only pill (POP) be used for?</h4><!-- end field 590c5261-9276-4d79-a403-a6ce0093f366 -->","summary":null,"htmlStringContent":"<!-- begin item 28bf27ea-69c6-4c37-b41e-a6ce0093f1ca --><!-- begin field c43f2795-aecd-4f85-bc90-a6ce0093f366 --><ul><li><strong>If the woman is not amenorrhoeic,</strong> continue the progestogen-only pill (POP) over 55 years of age until she has been amenorrhoeic for 1 year. </li><li><strong>If the woman is amenorrhoeic</strong>, consider one of the following options:<ul><li>For a woman over the age of 50 years, check serum follicle stimulating hormone (FSH) levels on two occasions, with an interval of 6 weeks between tests. If both FSH levels are more than 30 IU/L, stop the POP after a further year.</li><li>Continue the POP until the age of 55 years if required and requested.</li></ul></li></ul><!-- end field c43f2795-aecd-4f85-bc90-a6ce0093f366 --><!-- end item 28bf27ea-69c6-4c37-b41e-a6ce0093f1ca -->","subChapters":[]},{"id":"e555c77f-2eb6-5619-a662-9c954d7a9bcf","slug":"basis-for-recommendation-0e7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 61013980-bdad-44c2-b05a-b65c8e3236be --><h4>Basis for recommendation</h4><!-- end field 61013980-bdad-44c2-b05a-b65c8e3236be -->","summary":null,"htmlStringContent":"<!-- begin item 0e709fb4-2310-4fa6-a465-35e11dbbb42d --><!-- begin field 3806d4aa-30b3-4f1e-9fda-50af3683fa2d --><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guidelines <em>Progestogen-only pills</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2015a</a>], <em>Contraception for women aged over 40 years</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">FSRH, 2010b</a>] and expert opinion in a medical textbook, <em>Contraception today</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-progestogen-only-methods/references/\">Guillebaud, 2016</a>].</p><!-- end field 3806d4aa-30b3-4f1e-9fda-50af3683fa2d --><!-- end item 0e709fb4-2310-4fa6-a465-35e11dbbb42d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}